Search

everythinglearnresearchcommunity

for

Search:↓

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Skin emergency severity rises with other health issues and affects multiple organs; a new grading system can improve patient care.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Computer-aided imaging system accurately measures baldness in Chinese women with hair loss.

Hair loss in young men in Central India is linked to severe heart disease.

Severe hair loss (androgenetic alopecia) is linked to higher risk of heart disease (cardiovascular atherosclerosis).

MRI helps evaluate androgenetic alopecia severity.

A device was made in 2008 to measure hair loss severity. Other findings include: frizzy mutation in mice isn't related to Fgfr2, C/EBPx marks preadipocytes, Cyclosporin A speeds up hair growth in mice, blocking plasmin and metalloproteinases hinders healing, hyperbaric oxygen helps ischemic wound healing, amniotic membranes heal wounds better than polyurethane foam, rhVEGF165 from a fibrin matrix improves tissue flap viability and induces VEGF-R2 expression, and bFGF enhances wound healing and reduces scarring in rabbits.

Low-dose isotretinoin is as effective as conventional doses for acne and has fewer side effects.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Steroids are the best treatment for Alopecia Areata with few side effects.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The document concludes that accurate diagnosis of hair disorders is crucial and requires a range of diagnostic methods.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Lash ptosis is more common and severe in people with congenital eyelid droop than in those with acquired eyelid droop or without eyelid droop.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Topical spironolactone may help treat ocular graft-versus-host disease with minimal side effects.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.